Back
Sarepta Therapeutics Vs. Arrowhead Pharmaceuticals Industry Stock Comparison
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
$118.99
Seasonality Move:
12.18%
Sell
15
ARWR
Arrowhead Pharmaceuticals
Last Price:
$19.46
Seasonality Move:
23.49%
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals [ARWR] share price is $19.47. The Score for ARWR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $118.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $19.47Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight selling pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 43.28 | Sell |
Chaikin Money Flow: | -1117882 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.92 - 130.54) | Sell |
Bollinger Bands (100): | (118.37 - 135.77) | Sell |
ARWR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 39.36 | Sell |
Chaikin Money Flow: | -1728338 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.09 - 24.35) | Sell |
Bollinger Bands (100): | (19.24 - 23.9) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.1 | Sell |
20-day SMA: | 125.31 | Sell |
50-day SMA: | 122.99 | Sell |
200-day SMA: | 129.64 | Sell |
8-day EMA: | 122.43 | Sell |
20-day EMA: | 123.17 | Sell |
50-day EMA: | 123.7 | Sell |
200-day EMA: | 126 | Sell |
ARWR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.34 | Sell |
20-day SMA: | 22.49 | Sell |
50-day SMA: | 21.1 | Sell |
200-day SMA: | 23.71 | Sell |
8-day EMA: | 21.07 | Sell |
20-day EMA: | 21.7 | Sell |
50-day EMA: | 21.53 | Sell |
200-day EMA: | 23.77 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.11 per share, and an increase next year of $1.21 per share.
Sarepta Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arrowhead Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |